Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-27

Clinical Trial Update: Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing how exercise and inhibition of dipeptidyl peptidase-4 affect insulin secretion in people with Type 1 diabetes; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Diabetes Mellitus Type 1 | Phase 2 | Status: COMPLETED